Cargando…
To rechallenge or not to rechallenge, that is the question? An unsuccessful attempt of hypomethylating agent plus venetoclax in an elderly FLT3-positive relapsed acute myeloid leukemia patient after a yearlong period of remission
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361949/ https://www.ncbi.nlm.nih.gov/pubmed/35906348 http://dx.doi.org/10.1007/s00277-022-04938-0 |
| _version_ | 1784764630559621120 |
|---|---|
| author | Sevindik, Omur Gokmen Mergen, Mahmut Mergen, Sena Mutlu, Yasa Gul Aydın, Berrin Balık Serin, Istemi |
| author_facet | Sevindik, Omur Gokmen Mergen, Mahmut Mergen, Sena Mutlu, Yasa Gul Aydın, Berrin Balık Serin, Istemi |
| author_sort | Sevindik, Omur Gokmen |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9361949 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93619492022-08-10 To rechallenge or not to rechallenge, that is the question? An unsuccessful attempt of hypomethylating agent plus venetoclax in an elderly FLT3-positive relapsed acute myeloid leukemia patient after a yearlong period of remission Sevindik, Omur Gokmen Mergen, Mahmut Mergen, Sena Mutlu, Yasa Gul Aydın, Berrin Balık Serin, Istemi Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2022-07-29 2022 /pmc/articles/PMC9361949/ /pubmed/35906348 http://dx.doi.org/10.1007/s00277-022-04938-0 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Sevindik, Omur Gokmen Mergen, Mahmut Mergen, Sena Mutlu, Yasa Gul Aydın, Berrin Balık Serin, Istemi To rechallenge or not to rechallenge, that is the question? An unsuccessful attempt of hypomethylating agent plus venetoclax in an elderly FLT3-positive relapsed acute myeloid leukemia patient after a yearlong period of remission |
| title | To rechallenge or not to rechallenge, that is the question? An unsuccessful attempt of hypomethylating agent plus venetoclax in an elderly FLT3-positive relapsed acute myeloid leukemia patient after a yearlong period of remission |
| title_full | To rechallenge or not to rechallenge, that is the question? An unsuccessful attempt of hypomethylating agent plus venetoclax in an elderly FLT3-positive relapsed acute myeloid leukemia patient after a yearlong period of remission |
| title_fullStr | To rechallenge or not to rechallenge, that is the question? An unsuccessful attempt of hypomethylating agent plus venetoclax in an elderly FLT3-positive relapsed acute myeloid leukemia patient after a yearlong period of remission |
| title_full_unstemmed | To rechallenge or not to rechallenge, that is the question? An unsuccessful attempt of hypomethylating agent plus venetoclax in an elderly FLT3-positive relapsed acute myeloid leukemia patient after a yearlong period of remission |
| title_short | To rechallenge or not to rechallenge, that is the question? An unsuccessful attempt of hypomethylating agent plus venetoclax in an elderly FLT3-positive relapsed acute myeloid leukemia patient after a yearlong period of remission |
| title_sort | to rechallenge or not to rechallenge, that is the question? an unsuccessful attempt of hypomethylating agent plus venetoclax in an elderly flt3-positive relapsed acute myeloid leukemia patient after a yearlong period of remission |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9361949/ https://www.ncbi.nlm.nih.gov/pubmed/35906348 http://dx.doi.org/10.1007/s00277-022-04938-0 |
| work_keys_str_mv | AT sevindikomurgokmen torechallengeornottorechallengethatisthequestionanunsuccessfulattemptofhypomethylatingagentplusvenetoclaxinanelderlyflt3positiverelapsedacutemyeloidleukemiapatientafterayearlongperiodofremission AT mergenmahmut torechallengeornottorechallengethatisthequestionanunsuccessfulattemptofhypomethylatingagentplusvenetoclaxinanelderlyflt3positiverelapsedacutemyeloidleukemiapatientafterayearlongperiodofremission AT mergensena torechallengeornottorechallengethatisthequestionanunsuccessfulattemptofhypomethylatingagentplusvenetoclaxinanelderlyflt3positiverelapsedacutemyeloidleukemiapatientafterayearlongperiodofremission AT mutluyasagul torechallengeornottorechallengethatisthequestionanunsuccessfulattemptofhypomethylatingagentplusvenetoclaxinanelderlyflt3positiverelapsedacutemyeloidleukemiapatientafterayearlongperiodofremission AT aydınberrinbalık torechallengeornottorechallengethatisthequestionanunsuccessfulattemptofhypomethylatingagentplusvenetoclaxinanelderlyflt3positiverelapsedacutemyeloidleukemiapatientafterayearlongperiodofremission AT serinistemi torechallengeornottorechallengethatisthequestionanunsuccessfulattemptofhypomethylatingagentplusvenetoclaxinanelderlyflt3positiverelapsedacutemyeloidleukemiapatientafterayearlongperiodofremission |